We found that after 2 hr of AD treatment, RSK2 was phosphorylated at Ser227 (∼1.6-fold) in the N-terminal kinase domain (NTKD) and Thr577 (∼1.6-fold) in the C-terminal kinase domain (CTKD). This evidence concerns the gene RPS6KA3 and Alzheimer disease.